Atrial Fibrillation Trial, Recruiting NCT06099106 Sponsor: Endomatic Ltd. Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06099106
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a score of 2 or higher on a standard stroke risk calculator used for people with atrial fibrillation (called the CHA2DS2-VASc score)
  • You are not a good candidate for long-term blood thinning medication, or there is a good reason to look for a non-medication alternative to prevent blood clots
  • You have been diagnosed with atrial fibrillation (an irregular heartbeat) that is not caused by a heart valve problem
  • You are considered healthy enough to undergo a heart or blood vessel procedure
  • The specific part of your heart being targeted (the left atrial appendage) has measurements that are suitable for the study device

Who may not be able to join:

  • You need blood thinning medication for a reason other than atrial fibrillation
  • Your heart failure has been classified as the most severe level (confirm with trial site)
  • You have a complex heart defect that you were born with
  • You have a stent in a specific heart artery called the circumflex coronary artery
  • You have an artificial heart valve anywhere in your heart
  • You have previously had a procedure to close a hole in your heart, or you have a device in place for this purpose
  • You have a blood clot inside your heart
  • You have had any heart surgery in the past
  • Your heart's pumping strength is below a certain level (less than 35%) (confirm with trial site)
  • You have a moderate or severe narrowing of your mitral heart valve

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +972 (0)544595839

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Endomatic Ltd.
Registry
ClinicalTrials.gov
Start date
1 May 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇬🇪 Georgia 🇱🇹 Lithuania 🇵🇱 Poland Uzbekistan

Primary endpoints

SEPIOLA System Safety

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov